TORONTO, June 27, 2014 /CNW/ - MedCannAccess is proud to be a financial contributor and attendee at the 24th annual International Cannabinoid Research Society (ICRS) Symposium in Baveno, Italy.
"We are looking forward to attending ICRS' symposium again this year, focusing on new research that can be commercialized and utilized in our suite of cannabis based products", said Rade Kovacevic, VP Business Development. "We believe that collaboration with the research community will allow MedCannAccess to continue to be a leader in the field of medical cannabis; with a strong focus on innovations which benefit patients."
The Symposium runs from June 28th – July 3rd, providing a venue for the world's leading cannabinoid researchers to present their latest findings.
"The ICRS Symposium is the top international cannabinoid research event, providing opportunities to network and collaborate with the world's foremost researchers and cannabis based companies", Mr. Kovacevic continued. "We believe it is important that we financially support public research so that we can move society's understanding of medical cannabis forward, towards an evidenced based approach."
MedCannAccess is established to provide access to the highest-quality of medical cannabis products developed through research and innovation, improving the quality of life for persons with a wide range of conditions including chronic disabilities and terminal illnesses. MedCannAccess is a proud member of the Canadian Medical Cannabis Industry Association, Toronto Board of Trade, Guelph Chamber of Commerce and Ontario Chamber of Commerce.
For further information: Media Contact: Rade Kovacevic, VP Business Development: 519-780-7830